Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection

被引:498
作者
Beer, PM
Bakri, SJ
Singh, RJ
Liu, WG
Peters, GB
Miller, M
机构
[1] Albany Med Coll, Lions Eye Inst, Dept Ophthalmol, Albany, NY 12208 USA
[2] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA
[3] Johns Hopkins Univ Hosp, Wilmer Eye Inst, Ocular Immunol Serv, Baltimore, MD 21287 USA
[4] Albany Med Coll, Dept Med, Albany, NY 12208 USA
关键词
D O I
10.1016/S0161-6420(02)01969-3
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To describe the pharmacokinetics occurring after the direct injection of triamcinolone acetonide into the vitreous humor of humans. Design: Interventional case series. Participants. Five patients who received a single 4-mg intravitreal injection of triamcinolone acetonide. Methods: An aqueous humor sample was obtained from 5 eyes via an anterior chamber paracentesis at days 1, 3, 10, 17, and 31 after injection. At each visit, visual acuity and intraocular pressure were measured and indirect ophthalmoscopy was performed. A fluorescein angiogram was carried out at day 10. Concentrations were determined using high performance liquid chromatography; pharmacokinetic analysis was carried out using PK Analyst, an iterative, nonlinear, weighted, least-squares regression program. Main Outcome Measures: Intraocular concentrations of triamcinolone were measured and population pharmacokinetic parameters were calculated. Results: Pharmacokinetic data followed a two-compartment model. Peak aqueous humor concentrations ranged from 2151 to 7202 ng/ml, half-lives from 76 to 635 hours, and the integral of the area under the concentration-time curve (AUC(0-t)) from 231 to 1911 ng/h per milliliter. After a single intravitreal injection of triamcinolone, the mean elimination half-life was 18.6 days in nonvitrectornized patients. The half-life in a patient who had undergone a vitrectomy was shorter at 3.2 days. Conclusions: There was considerable intrasubject variation among peak concentration, AUCO-t values, and elimination half-lives. After intravitreal injection, measurable concentrations of triamcinolone would be expected to last for approximately 3 months (93 +/- 28 days) in the absence of a vitrectomy. Because triamcinolone pharmacokinetics were characterized only in elderly patients with macular edema, the results cannot be extrapolated to other patient populations. (C) 2003 by the American Academy of Ophthalmology.
引用
收藏
页码:681 / 686
页数:6
相关论文
共 20 条
[1]   NEW LOOK AT STATISTICAL-MODEL IDENTIFICATION [J].
AKAIKE, H .
IEEE TRANSACTIONS ON AUTOMATIC CONTROL, 1974, AC19 (06) :716-723
[2]   Intravitreal triamcinolone for uveitic cystoid macular edema: An optical coherence tomography study [J].
Antcliff, RJ ;
Spalton, DJ ;
Stanford, MR ;
Graham, EM ;
Ffytche, TJ ;
Marshall, J .
OPHTHALMOLOGY, 2001, 108 (04) :765-772
[3]   Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up [J].
Challa, JK ;
Gillies, MC ;
Penfold, PL ;
Gyory, JF ;
Hunyor, ABL ;
Billson, FA .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF OPHTHALMOLOGY, 1998, 26 (04) :277-281
[4]  
Danis RP, 2000, RETINA-J RET VIT DIS, V20, P244, DOI 10.1097/00006982-200003000-00004
[5]   DETERMINATION OF ROBUST OCULAR PHARMACOKINETIC PARAMETERS IN SERUM AND VITREOUS-HUMOR OF ALBINO RABBITS FOLLOWING SYSTEMIC ADMINISTRATION OF CIPROFLOXACIN FROM SPARSE DATA SETS BY USING IT2S, A POPULATION PHARMACOKINETIC MODELING PROGRAM [J].
DRUSANO, GL ;
LIU, WG ;
PERKINS, R ;
MADU, A ;
MADU, C ;
MAYERS, M ;
MILLER, MH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (08) :1683-1687
[6]  
Grasela TH, 1986, PHARMACOKINETICS PHA, P85
[7]  
Jaffe GJ, 2000, INVEST OPHTH VIS SCI, V41, P3569
[8]   Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema [J].
Jonas, JB ;
Söfker, A .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 132 (03) :425-427
[9]   Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy [J].
Jonas, JB ;
Hayler, JK ;
Panda-Jonas, S .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (09) :1064-1067
[10]   BIOCHEMICAL QUANTIFICATION OF TRIAMCINOLONE IN SUBCONJUNCTIVAL DEPOTS [J].
KALINA, PH ;
ERIE, JC ;
ROSENBAUM, L .
ARCHIVES OF OPHTHALMOLOGY, 1995, 113 (07) :867-869